Purpose: To describe the clinical outcome of corneal cross-linking (CXL) in a young child with keratoconus.
K eratoconus is a noninflammatory corneal dystrophy characterized by changes in the collagen structure and organization. Reduced collagen cross-linking and increased pepsin digestion are probably responsible for the structural weakness of the cornea, which in the case of keratoconus has a stiffness of only 60% of the normal cornea. 1 The reduced mechanical stability of the cornea leads to ectasia with impaired vision caused by irregular astigmatism, progressive myopia, corneal thinning, and occasionally corneal scarring. Corneal cross-linking (CXL) with riboflavin and UV-A irradiation has been established as an effective treatment option. CXL has been demonstrated to stop the progression of keratoconus in both adults and children, possibly avoiding the need for keratoplasty. [2] [3] [4] Especially in children, keratoconus is often more advanced at the time of diagnosis than in adults and progresses more rapidly. 5 We report the case of a girl with Down syndrome, who was diagnosed with bilateral keratoconus and secondary amblyopia at the age of 4 years. Because of documented progression, a decision to perform CXL in early childhood was made. , shortly thereafter, epi-off CXL was performed under general anesthesia using a standard Dresden protocol. 6 Intraoperative pachymetry was performed using a Tomey SP-100 ultrasound pachymeter (Tomey), showing corneal thinning to 290 mm. Corneal swelling was induced with hypoosmolar riboflavin. Repeated intraoperative pachymetry revealed a thickness of 400 mm. The eye was irradiated for 30 minutes with UV-A (3 mW/cm 2 , UV-X-1000; IROC Innocross, Zug, Switzerland).
CASE REPORT
A year later, CXL was also performed in the right eye because of progressive thinning and increasing curvature of the cornea Topographic and tomographic measurements at the last follow-up (ie, 2 years for the right eye and 3 years for the left eye) are shown in Figures 1-3 . A marked bilateral flattening effect was observed within the first postoperative year. Topographies stabilized over the next 2 years in the left eye, whereas slight progression was observed during the second year of follow-up in the right eye, but the values were still flatter compared with preoperative measurements (Fig. 1A) . The corneal thickness remained stable after initial thinning (Fig. 1B) 
DISCUSSION
We report the outcome of CXL in a 4-year-old child with progressive keratoconus with a follow-up of 3 years. This case demonstrates that keratoconus can be diagnosed at a very young age. To our knowledge, this patient is one of the youngest ever described. It may be speculated that Down syndrome is a risk factor for the early onset of the disease; and eye rubbing was never noted during visits or reported by the parents. In our clinical experience, fast progression of keratoconus as in this child is not untypical in very young children. Hence, an early diagnosis and recognition of progression are even more important.
In our case, further keratoconus progression was arrested and visual acuity was stabilized after CXL. As described for older patients with keratoconus in previous studies, the initial deterioration of all keratoconus indices, probably induced by the epithelial debridement, was followed by a continuous improvement of most of the indices during the observed period. 3 The marked corneal thinning after CXL has also been described. 3 Although transepithelial CXL might have some advantages particularly in regard to complications and comfort, 7 we decided to perform epi-off CXL because of better evidence for its efficacy. 8 Discussion about transepithelial CXL is ongoing, especially because of the reduced penetration of riboflavin through the intact epithelium and partial blockage of UV-A light from reaching the stroma. 9 In an animal model, Wollensak and Iomdina 10 revealed that corneal CXL without epithelial debridement reduced the biomechanical effect by approximately one-fifth compared with standard epi-off CXL. CXL is a very safe procedure when performed correctly, that is, under sterile conditions and with postoperative topical antibiotics. The risk for infectious keratitis is very low, probably because of the fact that the treated patients are young and without corneal surface problems, so that reepithelialization is fast. When performing CXL in very young children, such as in our case, the additional risks of general anesthesia have to be taken into account.
Consistent topographic and tomographic measurements can be challenging in young children, especially in those with Down syndrome, because of poor fixation and lack of concentration. In our case, good measurements were obtained thanks to a very cooperative and quiet girl, helpful parents, and very experienced technicians. In our experience, repeated measurements with several machines and on different days may be necessary to diagnose and follow keratoconus in young children.
Our case shows that standard epi-off CXL may be safe and effective in arresting keratoconus progression in early childhood.
